Health benefit considerations for the development of fish advisory guidelines for PFOS

Area of Science:

• Environmental Health
• Toxicology
• Nutritional Science

Background:

• Perfluorooctane sulfonate (PFOS) bioaccumulates in freshwater fish, leading to consumption advisories.
• Toxicity assessments indicate low PFOS reference doses may be exceeded by fish consumption.
• PFOS removal from fish is difficult, necessitating consideration of both toxicity and nutritional benefits.

Purpose of the Study:

• To review evidence on fish consumption benefits and PFOS noncancer health endpoints.
• To examine biological pathways where omega-3 polyunsaturated fatty acids (PUFAs) may counteract PFOS toxicity.
• To support a risk-benefit framework for PFOS fish advisories.

Main Methods:

• Narrative review of epidemiological and mechanistic studies.
• Synthesis of evidence on PFOS noncancer endpoints (immune, hepatic, cardiovascular, developmental).
• Examination of n-3 PUFA modulation of PFOS toxicity via nuclear receptors, inflammation, and lipid regulation.

Main Results:

• Evidence suggests n-3 PUFAs may counterbalance PFOS toxicity through various biological pathways.
• A risk-benefit framework for PFOS advisories is supported, acknowledging potential offsets.
• Data gaps exist, particularly for biomonitoring of PFOS and nutrient co-exposures.

Conclusions:

• Public health decisions on PFOS fish advisories require balancing risks and nutritional benefits.
• Further research is needed to quantify the interplay between PFOS exposure and fish nutrient intake.
• A nuanced approach is crucial for individuals relying on local fish for nutrition.